- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Docs Irate Over 'Doc Fix' Patch; Fight Shifts to Senate
Doctors are trying to stoke a rebellion against the doc fix.
Doctors are trying to stoke a rebellion against the doc fix.
A one-year extension of the doc-fix patch passed the House by voice vote Thursday, and so efforts to derail the measure now move to the Senate, where Senate Majority Leader Harry Reid (D-Nev.) has reportedly scheduled a vote for Monday.
The American Medical Association issued a statement from President Dr. Ardis Dee Hoven saying the association “is extremely disappointed in today's House action to give up on SGR repeal. There was bipartisan, bicameral support for reform this year, yet too many in Congress lacked the courage and wherewithal to permanently fix Medicare to improve care for patients and provide greater certainty for physician practices. Congressional leadership had to resort to trickery to pass an SGR patch that was opposed by physicians.”
Dr. Charles Mick, an orthopedic surgeon from Northampton, Mass., and a past president of the North American Spine Society, expressed disappointment that congressional leaders once again opted for a patch. “All of us had been very optimistic that this was the best chance in many years for a permanent fix to the SGR problem,” he said.
Read the full story here: http://bit.ly/1jPOHXP
Source: Modern Healthcare
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
A Focus on MAHA, Lasting Changes to Health Care Programs for Trump’s Second Term
March 13th 2025The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance exchanges, as well as highlight the Make America Healthy Again (MAHA) movement, speakers at the Value-Based Insurance Design Summit said.
Read More
